Work

Phase 2 trial of tisotumab vedotin in platinum-resistant ovarian cancer (innovaTV 208).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.tps5602

Authors: Haider Mahdi, Steven Robert Schuster, David M. O'Malley, Donna M. McNamara, Reshma A. Rangwala, Shang-Ying Liang, Shweta Jain, Leonardo Nicacio, Hye Sook Chon

Institutions: Cleveland Clinic, Poudre Valley Hospital, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Hackensack University Medical Center, Genmab (United States), Seagen (United States), Moffitt Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2946989458

Cites:

Cited by: 13

Related to: 10